J Gynecol Oncol.
2018 Jan;29(1):e15. 10.3802/jgo.2018.29.e15.
Trends of low-grade serous ovarian carcinoma in the United States
- Affiliations
-
- 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA. koji.matsuo@med.usc.edu
- 2Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
- 3Department of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan.
- 4Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.
- 5Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- KMID: 2395242
- DOI: http://doi.org/10.3802/jgo.2018.29.e15
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Differences of EDR Chemoresistance Assay and Prognosis between Recurrent Micropapillary Serous Ovarian Carcinoma and Serous Ovarian Carcinoma
- MAD2 Expression in Ovarian Carcinoma: Different Expression Patterns and Levels among Various Types of Ovarian Carcinoma and Its Prognostic Significance in High-Grade Serous Carcinoma
- Expression of TLR-4 in epithelial serous ovarian cancer
- Two Cases of Primary Papillary Serous Peritoneal Carcinoma
- Mutational Analysis of KRAS, BRAF, and TP53 Genes of Ovarian Serous Carcinomas in Korean Women
